• Explore /
  • Poster
  • / Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).

Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).

Abstract Poster

Authors

null

Pamela Jean Goodwin

Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

Pamela Jean Goodwin , Wendy Parulekar , Karen A. Gelmon , Lois E. Shepherd , Jennifer A. Ligibel , Dawn L. Hershman , Priya Rastogi , Ingrid A. Mayer , Timothy J. Hobday , Julie Lemieux , Alastair Mark Thompson , Kathleen I. Pritchard , Timothy Joseph Whelan , Som Dave Mukherjee , Haji I. Chalchal , Conrad D. Oja , Katia Sonia Tonkin , Vanessa Bernstein , Bingshu E Chen , Vuk Stambolic

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Triple-Negative Breast Cancer

Clinical Trial Registration Number

# NCT01101438

Citation

J Clin Oncol 31, 2013 (suppl; abstr 1033)

DOI

10.1200/jco.2013.31.15_suppl.1033

Abstract #

1033

Poster Bd #

25

Abstract Disclosures

Similar Posters

First Author: Dawn L. Hershman

First Author: Ryan JO Dowling

First Author: W. Parulekar

First Author: Mira F. Liebman